clinical trials

Over the weekend, Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant.

A novel weight loss drug in the same class as semaglutide has successfully met its targets in the largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight. The results strengthen its case for FDA approval.

A promising new treatment to combat "undruggable" cancers has been green-lit for a human trial. It's hoped the novel drug will be able to stunt the growth and enable the effective treatment of cancers driven by the MYC oncogene and its MYC protein.

A final-stage clinical trial comparing a long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects. If approved, the drug could simplify patient care.

We could be on the verge of a major cancer breakthrough, with a new nanoparticle-based vaccine reportedly obliterating pancreatic cancer cells in preclinical trials. This success now takes it a step closer to a first-of-its-kind human trial.

Positive results from trials of an immune therapy in dogs with bone cancer have been used to fast-track the development of the drug to treat children with the same cancer. It highlights how leveraging our genetic similarity can advantage both species.

The first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration, providing a simpler, quicker and less invasive method of diagnosis and speedier intervention. It's a milestone moment for medical science.

Some people can’t get their bad cholesterol levels down, even if they take cholesterol-lowering meds. A clinical trial using a combination of existing and not-yet-released cholesterol tablets lowered bad cholesterol by almost half.

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.

Using an existing steroid-free topical foam daily significantly improved the signs and symptoms of psoriasis on the scalp and the body, according to a recent clinical trial. It could be a game-changer for people with the condition in both places.

Clinical trials of a minimally invasive treatment for degenerated spinal discs have produced impressive results, significantly reducing back pain severity and improving function. It may mean delaying surgical intervention or preventing it altogether.

The first once-daily oral GLP-1 medication could be on shelves by this time next year, making the weight-loss drug easier to take and potentially cheaper. In the race to be the first, Novo Nordisk has scored a huge win, while Pfizer has failed again.